2 C
New York
Wednesday, February 1, 2023

DermTech Inc. (NASDAQ: DMTK): Is It A Buying Opportunity Again?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. After-hours trades for DermTech Inc. (DMTK) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.01, or 0.23%, to $4.32. The DermTech Inc. has recorded 52,335 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that DermTech Announces the Foundational Assay of Its DermTech Melanoma Test (DMT) Is Recommended for Coverage by TRICARE.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.


Stocks Info

DMTK belongs to the Healthcare sector of the NASDAQ while operating in the Diagnostics & Research industry. At the end of the last regular session, the stock closed at $4.31 and fluctuated between $4.3900 as its day high and $3.0275 as its day low. The current market capitalization of DermTech Inc. is $132.14M. A total of 2.01 million shares were traded on the day, compared to an average of 623.95K shares.

Insider Activity

Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, DMTK has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 0 SELLs from insiders. Insiders purchased 0 shares during that period but sold 0.

In the most recent transaction, Ibarra Claudia sold 328 shares of DMTK for 2.22 per share on Dec 12. After the transaction, the Chief Operating Officer now owns 157,822 company shares. In a previous transaction on Dec 12, Wood Todd Michael sold 356 shares at 2.22 per share. DMTK shares that Chief Commercial Officer owns now total 214,110.

Among the insiders who sold shares, Wood Todd Michael disposed of 448 shares on Dec 08 at a per-share price of $2.32. This resulted in the Chief Commercial Officer holding 214,466 shares of DMTK after the transaction. In another insider transaction, Ibarra Claudia sold 2,496 shares at $2.32 per share on Dec 08. Company shares held by the Chief Operating Officer now total 158,150.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for DMTK in the last 3 months, the mean price target is $7.33 with high estimates of $13.00 and low estimates of $5.00. In terms of 52-week highs and lows, DMTK has a high of $16.33 and a low of $1.55.

As of this writing, DMTK has an earnings estimate of -$0.95 per share for the current quarter. EPS was calculated based on a consensus of 7 estimates, with a high estimate of -$0.74 per share and a lower estimate of -$1.01. The company reported an EPS of -$1.01 in the last quarter, which was -16.10% lower than expectations of -$0.87.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 7 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DMTK is Overweight with a score of 4.60. A total of 6 analysts rated the stock as Buy while 0 rated it as Overweight while 1 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles